Skin Health Skin Care & Cleansing Products When to Use Topical Antibiotics By Naveed Saleh, MD, MS Updated on July 02, 2023 Medically reviewed by Susan Bard, MD Fact checked by Zerah Isaacs Print Walk through the aisles of your local pharmacy, and you'll notice an array of over-the-counter antibiotics in the form of creams, salves, and ointments (think bacitracin and polysporin). However, just because you can freely purchase these products and apply them ad libitum doesn't mean that they work well. Furthermore, the improper use of topical antibiotics can pose a public health hazard in the form of increased antibiotic resistance. Overall, topical antibiotics have very few appropriate (evidence-based) uses. kate_sept2004 / Getty Images Acne When used to treat acne, topical antibiotics shouldn't be used as sole treatment (monotherapy) for more than 3 months. Mild to moderate acne can be treated with topical antibiotics like clindamycin, erythromycin, and mincycline in addition to benzoyl peroxide. When used in combination. benzoyl peroxide and topical antibiotics reduce the risk that resistant strains of Propionibacterium acnes (P. acnes) will emerge. Of note, P. acnes is a slow-growing, gram-positive bacteria that contribute to the development of acne. Clindamycin is probably more effective than erythromycin when treating acne long-term. Furthermore, clindamycin has been linked to decreases in the number of blackheads (comedones and microcomedones) typical of acne. In addition to being combined with benzoyl peroxide, clindamycin can also be combined with tretinoin for the treatment of acne. Some topical antibiotics not only fight bacterial infection but also reduce swelling. Wounds In the 1960s and 1970s, physicians discovered that the application of topical antibiotics to surgical wounds dramatically decreased the risk of infection. Furthermore, the moist environment in part established by the application of topical antibiotics promoted healing. More recently, less evidence suggests that topical antibiotics prevent infection in wounds. Nevertheless, many pharmacies still sell topical antibiotics with the promise that they help fight infection. For at least two reasons, the use of topical antibiotics can be unsafe. First, topical antibiotics and other antibiotics used with wound care contribute to the emergence of antibiotic-resistant bacteria, most notably MRSA. Second, people often develop an allergy to topical antibiotics like neomycin and bacitracin. These allergic reactions appear as dermatitis or skin inflammation and can be aggravated by continued application of topical antibiotics, which often happens with wound care. The decision whether to use topical antibiotics for wound care should best be left to your physician. Ultimately, topical antibiotics probably help only a small subset of patients with wounds like those who are immunocompromised or have diabetes. Moreover, with most minor surgical wounds — wounds created during an aseptic procedure like skin biopsy — topical antibiotics are probably unneeded. Impetigo Impetigo is a common skin or soft tissue infection usually caused by a staph or strep bacteria. In the 1980s and 1990s, the topical antibiotic mupirocin was considered better than neomycin or polymyxin at treating impetigo. In conclusion, topical antibiotics have very limited medical uses. At best, when you purchase topical antibiotics for self-treatment, you're likely wasting your money. At worst, you're contributing to antibiotic resistance and skin allergy. 8 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Williamson DA, Carter GP, Howden BP. Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns. Clin Microbiol Rev. 2017;30(3):827–860. doi:10.1128/CMR.00112-16 Hoover WD, Davis SA, Fleischer AB, Feldman SR. Topical antibiotic monotherapy prescribing practices in acne vulgaris. J Dermatolog Treat. 2014;25(2):97-99. doi:10.3109/09546634.2013.852297 Leheste JR, Ruvolo KE, Chrostowski JE, et al. P. Acnes-driven disease pathology: current knowledge and future directions. Front Cell Infect Microbiol. 2017. doi:10.3389/fcimb.2017.00081 Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016;21(8):1063. doi:10.3390/molecules21081063 Heal CF, Banks JL, Lepper PD, Kontopantelis E, van Driel ML. Topical antibiotics for preventing surgical site infection in wounds healing by primary intention. Cochrane Database Syst Rev. 2016;11(11):CD011426. doi:10.1002/14651858.CD011426.pub2 Bandyopadhyay D. Topical antibacterials in dermatology. Indian J Dermatol. 2021;66(2):117. doi:10.4103/ijd.IJD_99_18 Goossens A, Gonçalo M. Contact allergy to topical drugs. Contact Dermatitis. 2021:1019-1055. doi:10.1007/978-3-030-36335-2_38 Khan A, Wilson B, Gould IM. Current and future treatment options for community-associated MRSA infection. Expert Opinion on Pharmacotherapy. 2018;19(5):457-470. doi:10.1080/14656566.2018.1442826 Additional Reading Creech CB, Al-Zubeidi DN, Fritz SA. Prevention of Recurrent Staphylococcal Skin Infections. Infect Dis Clin North Am. 2015;29(3):429–464. doi:10.1016/j.idc.2015.05.007 By Naveed Saleh, MD, MS Naveed Saleh, MD, MS, is a medical writer and editor covering new treatments and trending health news. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit